Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 14, 2001

View Archived Issues

New Target For Thrombotic Drugs Could Increase Safety

Genset Cuts Back Genomics Focus, Moves On To Discovery

British Biotech's Marimistat Fails In Promising Indication

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Despite Resistance In France, Chirac Sees Place For GM Crops

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Curacyte Gets Into Full Swing With US$6.5M Seed Financing

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

French Advancing Legislation To Allow Therapeutic Cloning

Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs

Medica Strengthens Position With Kinase-Targeting Filings

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...